SELE and acute myeloid leukemia: Despite this, when compared to the total number of AML blasts in the BM and spleen of a leukemic mouse, only ~1% of total body AML blast relocated to the peripheral blood following GMI-1271 administration, or in a Sele−/− host (Supplementary Fig. 3).